CAREMARK RX INC 4
4 · CAREMARK RX INC · Filed Mar 26, 2007
Insider Transaction Report
Form 4
FINLEY SARA J
SVP, Sec. & Asst. Gen. Counsel
Transactions
- Disposition to Issuer
Stock Option
2007-03-22−50,000→ 0 totalExercise: $13.21From: 2001-11-07Exp: 2011-11-07→ Common Stock, par value $.001 (50,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−15,000→ 0 totalExercise: $18.35From: 2003-03-31Exp: 2013-03-31→ Common Stock, par value $.001 (15,000 underlying) - Disposition to Issuer
Common Stock, par value $.001
2007-03-22−4,493.38→ 0 total - Disposition to Issuer
Stock Option
2007-03-22−70,000→ 0 totalExercise: $50.84From: 2007-03-01Exp: 2016-03-01→ Common Stock, par value $.001 (70,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−10,000→ 0 totalExercise: $32.03From: 2005-05-10Exp: 2014-05-10→ Common Stock, par value $.001 (100,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−100,000→ 0 totalExercise: $37.92From: 2006-03-01Exp: 2015-03-01→ Common Stock, par value $.001 (100,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to a merger agreement between issuer and CVS Corporation at the rate of 1.67 shares of CVS/Caremark Corporation common stock for each share of issuer stock. All issuer shares held by Reporting Person were disposed.
- [F2]Issuer options are being replaced in the merger with CVS/Caremark Corporation options exercisable for CVS/Caremark Corporation common stock. The number of CVS/Caremark Corporation common shares and the exercise price of the CVS/Caremark Corporation replacement option will be computed using a formula that will result in the Reporting Person receiving an intrinsic value in the CVS/Caremark Corporation replacement option that will be approximately equal to the intrinsic value of the issuer options valued immediately prior to the merger.